This post has expired! It was posted more than 90 days ago.
<- Back

136102 - Diabetes Academy - What's New in Diabetes?

  • : Online


Diabetes management is rapidly evolving. Recent large randomized controlled cardiovascular outcome trials have provided the evidence for the introduction of a variety of new classes of medications available for use for people with type 2 diabetes. Advances in technology including the use of continuous glucose monitoring devices and insulin pumps are improving outcomes for people with type 1 diabetes. 
"Diabetes Academy - What’s New in Diabetes?" is an important clinical update discussing the keys to treatment for diabetes. The course is intended to increase the knowledge and confidence of clinicians caring for people with diabetes. More information: http://go.unimelb.edu.au/p3y6

Relevance to General Practice

Diabetes is a high-level priority chronic disease. Worldwide 422 million people are currently living with diabetes (1). There are at least 1.2 million Australians living with diabetes (2). Diabetes requiring treatment with insulin is increasing annually, currently 383,000 people per year requiring insulin (251,000 type 2 diabetes, 118,000 type 1 diabetes, 11,000 gestational diabetes). 
Diabetes is a major cause of increased morbidity and increased mortality to Australians. The major complications are coronary artery disease, peripheral vascular disease including leg ulcers and leg amputations, chronic kidney disease, and visual impairment. 
This online course by Diabetes Academy aims to address comprehensive diabetes care, including novel technologies and practical tips that GPs will be able to immediately put into practice. General practitioners will benefit from access to up to date resources and advice regarding diabetes and its management.

Learning outcomes
  • Organise and manage the comprehensive care of a patient with diabetes in order to prevent medication risks and reduce the risk of diabetes complications
  • Discuss the indications and benefits of novel medications in diabetes management, including GLP1 analogues, SGLT2 inhibitors and DPPIV inhibitors
  • Outline current guidelines in the management of gestational diabetes and pre-existing maternal diabetes
  • Use evidence-based guidelines for assessment and management of hypertension, including the use of Ambulatory Blood Pressure Monitoring.
  • Evaluate the care of a patient with new technologies such as an insulin pump or continuous glucose monitoring device
  • Delivery
    136102 - Diabetes Academy - What's New in Diabetes?
    12 hours
    Start Date
    End Date
    CPD Points
    12 hours
    Contact Phone
    Log in into view this field.